Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy | Health Policy and Reform
Links shared publicly online about this topic.
- 211total visits
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy | Health Policy and Reform
healthpolicyandreform.nejm.org —
Amy Egan, M.D., M.P.H., and Eric Colman, M.D. Statins are the most widely prescribed class of drugs for treating dyslipidemia — in particular, elevated
View full resource at healthpolicyandreform.nejm.org
Tags: Cholesterol, Cholesterol Medication, Muscle, Drug, Healthy Living, Zocor
Most Recently Shared on June 17, 2011 at 11:35 pm By:
Some concern about muscle breakdown with high dose statins (cholesterol lowering med). http://t.co/DwNPhnc
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy | Health Policy and Reform
healthpolicyandreform.nejm.org — “Amy Egan, M.D., M.P.H., and Eric Colman, M.D. Statins are the most widely prescribed class of drugs for treating dyslipidemia — in particular, elevated” View full resource at healthpolicyandreform.nejm.org
Most Recently Shared on June 16, 2011 at 1:24 am By:
Physician Assistants Health News Feed
Weighing Benefits of High-Dose Simvastatin against the Risk of Myopathy: http://bit.ly/lHvmmC FDA will closely monitor prescription-use data
Advertisement
